CMO/CDMO Market projects a CAGR of over 6% for the market growth through 2020 to 2030

An increasing number of companies within the pharmaceutical sector have been considering contract manufacturing in response to the increasing demand for generic drugs and biologics. In a new study, Future Market Insights (FMI) has forecast the global contract manufacturing/ contract development and manufacturing organization (CMO/ CDMO) market to surpass US$ 18 Bn by 2020.

According to the study, contract manufacturing accounts for 3/4th of all the CMO and CDMO services. Focus towards cost management, enhanced process flow, and better scalability will drive the market over the forecast period. Besides this, the increasing demand for skin care products, which also accounts for the leading share in terms of product type, will enable the market gain impetus in the coming years.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13038

Key Takeaways from CMO/CDMOs Market Study

  • CMO/ CDMO services has become highly sought-after in pharmaceutical and beauty industries. FMI has projected the market to report 6.2% CAGR between 2020 and 2030
  • The U.S. is expected to account for over 77% of sales in North America by 2030
  • The U.K. will represent impressive scope for expansion, exhibiting above 7% CAGR through the forecast period
  • The rising focus on healthcare and wellness spending will support growth in Germany and France
  • The availability of inexpensive labor and resources will continue supporting growth in China. However, Japan and South Korea markets are expected to register higher percentage of growth over the forecast period

“Manufacturers operating in the market are keen on forging strategic partnerships with leading cosmetics brands and pharmaceutical companies. Collaborations are expected to remain a primary strategy adopted by market players to gain competitive edge,” says FMI analyst

In terms of the effect of COVID-19 pandemic on the demand of CMO/CDMO services, there was a negative impact on the market growth. One of the major issues was related to the supply chain gap. Prior to COVID-19, contract manufacturing was one of the most preferred sectors in the growing beauty and personal care industry. However, due to the pandemic, the industry suffered major setbacks as expected product launches were delayed. A shift was observed in consumer habits. Reduction of sales of leading products was recorded along with production slowdowns, which caused overhead to curb the profitability.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-13038

Who is Winning?

Collaboration is the key strategy amongst market players. The CMO/CDMO companies continue to focus on collaborations to gain sustainability in the market.

  • For instance, In February 2021, Lonza signed an agreement to divest its specialty ingredients business to Bain Capital and Cinven, aiming to refocus as a pure-play partner to the healthcare industry.
  • In 2021, Pierre Fabre Group hosted a pioneering custom online partnering forum, partnering with biopharmaceutical firms aiming to accelerate the digital transformation of Pierre Fabre Group
  • In 2020, In March 2020, Pierre Fabre Group, in partnership with numerous hospitals in the Occitania region of France, donated hand care creams, body cleansing gels and thermal spring water sprays and hand sanitizers necessary to combat the spread of Covid-19.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-13038

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015-2030. The global CMO/CDMO market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on CMO/CDMO market on basis of service (Contract Development: Formulation development & Pilot studies, Contract Manufacturing: Bulk preparation & scale up, Safety Testing and Filling & Packaging (Close jars, Bottles, tubes, roll ons and others), on basis of product (Hair Products, Skin Products, Lip Products, Eye Products, Body hygiene and Oral hygiene), on basis of form (Solid form & powder, Lotions, Creams and Others) across seven key regions.

Radiation-Induced Fibrosis Treatment Market Competitive Growth Strategies Based on Type, Applications, End User and Region

According to the latest research by Future Market Insights, Radiation-Induced Fibrosis Treatment market is set to witness a 5.6% growth during the year 2021-2031. The market is expected to witness growth owing to increase in number of patients going through radiotherapy

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13900

or chemotherapy and the growing utilization of novel drug delivery methods like transdermal patches & combination therapies. Moreover, the market is furthermore influenced by technology advancements to discover novel high potential drugs, hence creating lucrative opportunities in the market.

What is Driving Demand for Radiation-Induced Fibrosis Treatment

Increasing occurrence of cancer and developments in research and development of medicines will help in boosting the development of the market.

Moreover, strong research and development in oncology treatment, the increase in the occurrence of cancer cases, growing preference toward chemotherapy for the treatment of cancer and the usage of chemotherapy in together with other cancer treatments are expected to drive the growth of radiation-induced fibrosis treatment.

In addition, the demand for the global market for radiation-induced fibrosis treatment is anticipated to grow on account of the increasing occurrence of different types of cancers worldwide.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-13900

Growing number of cancer cases, likely to boost Radiation-Induced Fibrosis Treatment Sales

Cancer is one of the leading cause of death across the world. As per the National Institutes of Health (NIH), in 2018, around 1,735,350 new cases of cancer were detected in the United States and 609,640 people died from the disease.

Cancer can be treated by chemotherapy, surgery, hormone therapy, radiation therapy, targeted therapy, stem cell transplantation and precision medicine.

The most common therapy for cancer is chemotherapy; it utilizes drugs to eradicate cancer cells which lead to pain and other problems. Chemotherapy can be used together with other cancer treatments.

Chemotherapy, kills the cancer cells as well as attacks healthy cells which results into side effects such as hair loss, fatigue, nausea, and vomiting. Radiation-induced fibrosis is the late indication of radiation-induced lung disease and is comparatively common following radiotherapy for intrathoracic or chest wall malignancies.

US and Canada Radiation-Induced Fibrosis Treatment Market Outlook

The US and Canada Radiation-Induced Fibrosis Treatment market is expected to observe a robust growth in the market owing to the increasing on account of the presence of various cancer-relief organizations and campaigns in the US and Canada.

Also, rising number of cancer cases is expected to boost the market in US.

As per the American Cancer Society’s annual report, around 1.6 million population was affected by cancer in US in 2017 and hence it is expected to occupy the highest market share in the market. In addition, advantageous government initiatives and rise in the number of research partnerships are few of the factors anticipated to increase market growth.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-13900

Europe Demand Outlook for Radiation-Induced Fibrosis Treatment

Europe is expected to be second most lucrative region for market owing to several factors.

The increasing patient pool leads to a high rate of radiation-induced fibrosis treatment drugs adoption because of rising number of patients with chemotherapeutic associated side effects.

Moreover, the increase in cancer patients, funding by the governmental bodies and focus on merger and acquisition by various key manufacturers is expected to lead to market growth.

Who are the Key Manufacturers and Suppliers of Radiation-Induced Fibrosis Treatment

Some of the leading manufacturers and suppliers of Radiation-Induced Fibrosis Treatment include

  • Merck & Co. Inc.
  • Galapagos NV
  • Biogen
  • Bristol-Myers Squibb Company
  • Prometic Life Sciences Inc.
  • Cipla Inc.
  • Pfizer, MediciNova, Inc.
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche
  • FibroGen, Inc.
  • Promedior, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Accord Healthcare
  • Zydus Cadila, and others.

The market is moderately competitive with presence of various major players. Technology partnerships and collaborations by the major players in the market with a view to bridge the demand-supply gap is expected to play a key role in development of the market.

Worldwide, they are involved in long term contracts with medical care organizations, and are involving into partnerships and strategic alliances with other players in various nations to extend their business. Also, major players are funding largely in the in the research and development to produce advanced products.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

The report also maps the qualitative impact of various market factors on market segments and geographies.

Global 3D Bioprinting Market Is Estimated To Surpass US$ 1.2 Bn By 2021 & Market CAGR Of 13% During The Forecast Period 2020-2030

Academic institutes and hospitals use 3D printing technology to develop various models for training purposes. The technology is increasing used in bio printing where biomaterials such as growth factors and cells are combined with bioink to create tissue-like structures that imitate natural tissues. The global 3D bioprinting market is estimated to surpass US$ 1.2 Bn by 2021, at the market CAGR of 13% during the forecast period (2020-2030), as per a new report by Future Market Insights (FMI).

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-808

3D bioprinting has immense potential to facilitate organ transplants and drug discovery. 3D printing can copy the actual macro and micro-environment of human organs and tissues which can solve the organ transplant crisis. Advancements in 3D printing technology and its promising applications in the healthcare industry are expected to increase the sale of 3D bioprinting over the forecast period.

As per the report, the technology will find increasing application in orthopedic implants manufacturing. The orthopedic implants segment is in fact forecast to account for over 30% of the market in terms of application.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-808

Key Takeaways from 3D bioprinting Marker Study

  • Exhibiting a little below 13% Y-o-Y growth in 2021, 3D bioprinting market will exhibit solid growth
  • The U.S. will register high demand, accounting for nearly 95% of sales in North America
  • Demand in U.K. is expected to rise significantly, exhibiting above 11% Y-o-Y growth in 2021
  • France and Germany too will register high demand
  • In East Asia, China and Japan are expected to emerge as key market

 “Launch of innovative 3D printers and application of 3D bioprinting in tissue engineering and regenerative medicine, medical device manufacturing will augment the growth of global 3D bioprinting market” says the FMI Analyst

Acquisitions, Partnerships and expansion are key Strategic Focus of 3D bioprinting Market Players

Leading players in the 3D bioprinting market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

  • In January 2021, 3D Systems announced its regenerative and bioprinting solutions expansion by actively investing in the regenerative areas, in collaboration with United Therapeutics Corporation.
  • In December 2019, GE Healthcare Life Sciences collaborated with Advanced Solutions Life Sciences (ASLS), a Kentucky-based biotechnology firm, to build an integrated 3D bioprinter by combining their digital advanced technologies.
  • In January 2020, GE Healthcare Life Sciences introduced a new additive manufacturing (AM) facility in Umeå, Sweden that will be dedicated to integrating 3D-printed parts into the company’s production of bio manufacturing equipment. With $2 million in backing, the new center is expected to increase biopharma manufacturers’ access to state-of-the-art technologies

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-808

Who is Winning?

The global market is set to expand its scope in the forecast period, due to rising prevalence of orthopedic disease globally and adoption of 3D bioprinting at various stages of development of orthopedic implants by medical manufacturers. In addition to this, cost effectiveness and increase adaption of 3D bioprinting in dental and regenerative medicine application has augmented the sales of 3D bioprinting.

The key market players covered by FMI include 3D Systems, Inc, GE Healthcare (Concept Laser, Arcam AB), EOS GmbH Electro Optical Systems, Renishaw plc, Stratasys Ltd, Ltd, EnvisionTEC, Formlabs, Inc And Organovo Holdings Inc, and Advanced Solutions Life Sciences, consolidating their positions through mergers, acquisitions and new product launches.

Centrifugal Blood Pumps Market Remains Strong As It Is Projected To Exhibit 4% CAGR Between 2020 And 2030

Future Market Insights (FMI) in a new study has projected that growth outlook for the centrifugal blood pumps market will remain strong. The market will exhibit 4% Y-o-Y growth in 2021 driven by rising cases of heart ailments recorded worldwide. A centrifugal ECMO pump is compact and delivers adequate volume of blood with relatively high pressure in order to compensate for the large pressure drop in the membrane oxygenator.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6451

Centrifugal pumps show improved blood handling capacity and are energy-efficient. In addition to this, centrifugal pumps are small in size and represent less capital investment and have low maintenance costs. The growing preference for centrifugal blood pumps over roller pumps from hospitals and ambulatory surgical centers due to their various advantages will enable growth in the market in the coming years.

Due to the COVID-19 outbreak health care systems are negatively impacted and delivery of medical facilities effectively to all patients has become a huge challenge worldwide. Medical device manufacturers have not escaped the pandemic’s impact. Similar to pharmaceutical companies, medical device manufacturers rely heavily on healthcare facilities for their clinical trial data collection. The COVID-19 in the first few months of 2020 has imparted a negative impact on the centrifugal blood pumps market. The massive global lockdown, along with the shutting down of the economies such as China has halted the demand and supply activities. Despite this, hospitals are likely to remain leading end users owing to the advanced infrastructure and expenditure and the presence well trained medical staff and advanced facilities.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-6451

Key Takeaways from Centrifugal Blood Pumps Market Study

  • Growth forecast for centrifugal blood pumps market remains strong as it is projected to exhibit 4% CAGR between 2020 and 2030
  • U.S. to spearhead growth in North America, accounting over 90% of centrifugal blood pumps sold
  • U.K. will showcase marginal yet steady growth 2.4% CAGR
  • Germany and France will continue exhibiting steady rise in demand
  • JAPAN and Korea to remain strong markets for centrifugal pumps in East Asia

“Companies operating in the market are focusing on research and development initiatives. Investment towards introducing advanced features will continue increasing through forecast period, enabling growth in the market” says the FMI Analyst

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-6451

Innovations to Remain Key to Growth

The rising demand for improved cardiac surgery will fuel the demand for centrifugal blood pumps. These pumps have low priming volume and limited contract surfaces, which make their applications ideal for certain conditions. Besides this, companies are increasingly focusing on technological innovations, which has led to the advent of lightweight centrifugal seamless blood pump with unique spherical thrust bearing.

These pumps also show the least blood trauma during cardiac surgery in comparison to other pumps available in the market, including roller pump. Advances in various cardiac assist devices aimed at curbing the incidence of adverse healthcare occurrences will continue creating growth prospects for the market.

Microbial Therapeutic Products Market Competitive Growth Strategies Based on Type, Applications, End User and Region

Future Market Insights’ (FMI) global microbial therapeutic products report provides an exhaustive yet unbiased analysis of future growth projections, taking into account the aforementioned developments to provide a bird’s eye view of the landscape. According to the study, demand for microbial therapeutic products is likely to grow at a steady clip, driven chiefly by growing incidence of antimicrobial resistance.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12891

Over the years, the burden of antimicrobial resistance (AMR) has been escalating tremendously, besides prevalence of chronic conditions. The World Health Organization observes high resistance rates have been observed against antimicrobials used for treating urinary tract infections and certain types of diarrhea. For example, the rate of resistance to ciprofloxacin ranged anywhere between 8.4% and 93% across 33 countries. It is apprehended that this burden is compounding further due to the COVID-19 pandemic. Hence, efforts are underway to accelerate research for discovering breakthroughs in microbial therapeutics.

Key Takeaways

  • By product, anti-cancer agents to capture nearly 30% revenue by 2020-end, owing to prolific research breakthroughs
  • By route of administration, injection pens to account for 2 out of 5 sales, attributed to patient hygiene concerns
  • By source, bacteria based microbial therapeutic products to remain preferred
  • Oncology to remain primary microbial therapeutic products application area, expanding at Y-o-Y rate exceeding 5% through 2020
  • Hospitals emerge as the primary microbial therapeutic end-users, attributed to availability of adequate infrastructure
  • North America to remain the market hegemon, East Asia to be fastest growing market

“Prominent manufacturers are seeking regulatory approvals to accelerate research and development operations for developing effective drug solutions to address the compounding antimicrobial resistance problems,” remarks the FMI analyst.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-12891

COVID-19 Impact Analysis

The COVID-19 pandemic has adversely impact global economic outlook, with a prolonged recession on the cards across numerous industries. However, the microbial therapeutic products market has only stood to benefit from the pandemic crisis, as the global healthcare community accelerates efforts to find a potential cure for this deadly virus.

With inoculation procedures already being initiated across the U.K., it is only a matter of time before the anti-COVID-19 vaccine is available on a global scale. Despite this availability, healthcare providers will have a long road ahead with respect to discovering an orally administered drug formulation.

Therefore, governments are lending unconditional support to the global healthcare fraternity in terms of policy relaxation and disbursement of financial grants to aid in the research and development process, catapulting growth prospects.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-12891

Competitive Landscape

Prominent players operating in the global microbial therapeutic products market are emphasizing on acquiring regulatory approvals, forging partnerships and collaborations with competent authorities and biosimilars develop to capture substantial revenue shares across key regions.

Some reputed players operating within the global microbial therapeutic products landscape include Dr. Reddy’s Laboratories, Pfizer Inc., Sanofi SA, Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Abbott Laboratories and Amgen Inc. to name a few.

Global Autoclaves Market Will Exhibit 5% CAGR Between 2020 And 2030

The global autoclaves market will exhibit 5% CAGR between 2020 and 2030, especially as demand for sterilization and disinfections continue rising across hospitals, academic and research institutes, biopharmaceutical companies, and other facilities, finds Future Market Insights (FMI) in a new study. As per the report, increasing cases of hospital acquired infections will encourage investment in autoclaves across healthcare facilities.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12890

According to the Centers for Disease Control and Prevention (CDC), on any given day, about 1 in 31 hospital patients has at least one health-care associated infection. Autoclaving destroys microorganisms with higher efficiency than dry heat. Hence autoclaves are registering increasing applications in the healthcare industry.

While the outbreak of novel coronavirus has taken a toll on the market affecting its growth, it is recovering steadily to bounce back. Patient admissions in hospitals and other healthcare facilities has increased, which is in turn fuelling the demand for autoclaves in the recent year.

FMI offers an in-depth analysis and overview of the global autoclaves market, covering factors enabling its growth, creating prospects, and key threats.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-12890

Some of the key takeaways from the report are highlighted below-

  • Rise in demand for gravity autoclaves is projected to fuel the growth of the market during the forecast period between 2020 and 2030
  • Floor standing autoclaves will gain traction due to the high for laboratory applications
  • The demand for front loading type autoclave is expected to be higher than top loading and pass through
  • Cylindrical autoclaves will be highly sought-after among chamber types
  • Academic and research institutes will continue exhibiting high demand for autoclaves
  • North America will dominate in the global market followed by Europe

“The rising awareness among the hospital staff, doctors, and patients regarding the hospital acquired infections is spurring the growth of the autoclaves market. The outbreak of COVID-19 pandemic has resulted in unbridled rise in patient pool across hospitals and healthcare centers, increasing the risk of hospital acquired infections. According to the National Centre for Biotechnology Information (NCBI), the risks of Central Line-Associated Bloodstream Infection (CLABSI), Catheter Associated Urinary Tract Infection (CAUTI), and others are higher in COVID-affected patients. This has been fuelling the demand for autoclaves and the trend is expected persist over the next couple of years,” says an FMI analyst.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-12890

COVID-19 Impact Analysis

The outbreak of COVID-19 pandemic caused decline in the growth of market earlier this year. The sudden lockdown, coupled with restrictions imposed, had severely affected manufacturing units of the autoclaves. However, autoclaves being an integral part of the sterilization process started experiencing surge in demand soon after getting over the temporary period of lull. The ongoing pandemic has resulted in higher requirement for sterilized and clean environment across healthcare facilities, which is substantially pushing the demand curve for autoclaves upward. As per Medical Product Outsourcing (MPO), autoclaves are staples in the healthcare industry and they are used extensively for high-pressure steam sterilization on various tools and industrial components, especially during COVID-19 pandemic.

According to the World Health Organization (WHO), biosafety levels BSL-2 and BSL-3 are required in order to handle COVID-19 by maintaining clean and safe environment. As laboratory autoclaves are ideal for sterilization of contaminated instruments, waste, laboratory equipment, and others while maintaining these standards, they are highly required in diverse end-user industries starting from pathology laboratories to academic and research institutes.

Who is Winning?

Competition in the global autoclaves market has been rising steadily. In order to strengthen their foothold, market players are focusing their efforts towards exploring and capitalizing on new opportunities. This has resulted in a slew of product launches in the last few years.

For instance, Benchmark Scientific has launched their new range of BIOCLAVE™ RESEARCH AUTOCLAVES which are designed specifically for laboratory research tools and provide fully automatic services in the current year.

Panasonic Biomedical has launched their new extensive range of laboratory autoclaves such as MLS-3020U, MLS-3751L, MLS-3781L, and others in the recent year.

Global Transradial Closure Devices Market Is Set To Grow By 6.5% CAGR During The Forecast Period From The Year 2020 To 2030

The transradial closure devices market is growing with the increasing cases of cardio vascular diseases all over the world. A new study by Future Market Insights (FMI) has projected the market to rise at 6.5% CAGR between 2020 and 2030. According to the report, demand will rise consistently on the back of surging cases of cardiovascular ailments caused by stress, unhealthy lifestyle, and others factors.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12841

According to World Health Organization (WHO), every year cardiovascular diseases cause an estimated 31% of death occurring worldwide. Also a 2016 Heat Disease and Stroke Statistics update by the American Heart Association stated that over 15 million people in the U.S. have coronary heart disease.

With no signs of the incidence slowing down, the demand for procedures such as angiography, angioplasty, percutaneous coronary intervention (PCI), and others will continue rising. Consequently, the demand for transradial closure devices is surging rapidly all over the world.

Radial access is highly efficient in providing faster mobility to patients due to smaller incision.  Furthermore, chances of infection at site is lower in radial access as compared to transfemoral access, which makes it highly preferred by diverse end users, starting from hospitals to specialized clinics.

The outbreak of COVID-19 pandemic is anticipated to impact the market negatively. The temporary period of lull could continue until the next year. However, the transradial closure devices market has high potential to grow further in the coming years.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-12841

FMI offers an exhaustive overview of the transradial closure devices market, its growth drivers, and restraints.

Some of the key takeaways from the report are highlighted below-

  • Band or strap based transradial closure type devices are expected to lead in the market during the forecast period
  • Disposable devices are anticipated to gain traction in terms of usage
  • Application of transradial devices in diagnostic segment will remain high throughout the forecast period
  • Among the end users, independent catheterization centres will emerge dominant in the coming years
  • North America will lead in the global market followed by Europe

“Due to the rising cases of cardio vascular diseases, there has been increase in surgical and diagnostic procedures related to it. Transradial access (RA) being associated with less complications, is highly preferred by the various end users such as ambulatory surgical centers, hospitals, and others. In the coming years, the uptake of transradial closure devices will therefore rise especially since patients are increasingly willing to spend on procedures that ensure shorter hospital stays,” says an FMI analyst.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-12841

COVID-19 Impact Analysis

Due to the outbreak of COVID-19 pandemic, manufacturing process of transradial closure devices was hampered during the lock down. Contrary to this, novel coronavirus might cause cardiovascular concerns, which has resulted in surge in demand for the transradial closure devices in hospitals, specialized clinics, and other segments.

As per the latest study by FMI, the global transradial closure devices market has high potential to overcome the threats posed by the ongoing pandemic and grow further in the coming years.

Who is Winning

The global transradial closure devices market is highly competitive. In order to strengthen their foothold market players are focusing on the launch of ultra-modern transradial closure devices.

For instance, Comed B.V has launched their new Io™ Radial Compression Tourniquet (Io™ RACT) which is effective to compress the radial artery puncture, post procedure in the current year. Their Io™ RACT is small, and especially designed to optimize compression, view the puncture side and deflate the compression balloon.

Merit Medical, Inc. has launched their exclusive PreludeSYNC™ Radial Compression Device which assists in achieving vascular hemostasis in the recent year. Their PreludeSYNC™ Radial Compression Device is available with the safety and convenience of a specialized connection device and syringe.

Alumina Trihydrate Market Will Generate Revenue, Totaling US$ 4 Bn In 2021 & Market Is Forecast To Exhibit CAGR Of 7.7% During The Forecast Period

Alumina trihydrate sales reached 6724.7 KT in 2021, which are likely to see a healthy 4.5% Y-o-Y increase in 2021. Future Market Insights (FMI) indicates that the gains will remain highly influenced by the increasing use of plastics in the automotive and transportation industry. The industrial application of alumina trihydrate in chemicals, plastics, paper, paints and coatings, among others.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-335

Captive consumption has been an important trend in the alumina trihydrate landscape. While over 70% of alumina trihydrate production is dedicated to captive consumption by manufacturers, the rest is directed to end-use sectors operating within paints & coatings, paper, plastics, construction, and a few other industries.

Plastics and chemicals will remain the key end users of alumina trihydrate, which currently account for more than 60% shares in the market. Consumption of alumina trihydrate in production of alum will particularly remain the prominent point of revenue generation over the forthcoming years. Widening applicability across a multitude of industrial verticals will enable this high-volume market to demonstrate an impressive growth curve through the next decade.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-335

According to report findings, end use of alumina trihydrate in plastics is anticipated to contribute for significant value shares, which has primarily resulted from the increasing applications of alumina trihydrate in engineering plastics. Chemicals, on the other side, are expected to maintain the lead in terms of end use, which is driven by the production of aluminum sulphate (alum) and aluminum chloride. Alum and aluminum chloride find major application as a coagulant in the water treatment sector.

APEJ Market’s Attractiveness Rising

Regions such as North America and APEJ are anticipated to hold significant market shares in terms of value. However, the APEJ market is anticipated to project lucrative growth in the global alumina trihydrate market during the forecast period of 2021-2031. This growth is driven by the rising usage of alumina trihydrate in end-use industries such as plastics, chemicals, papers, paints and coatings of APEJ that include India and China countries, among others. Countries such as China and India have shown positive economic growth.

Furthermore, owing to the effects of macroeconomic factors such as growing population, urbanization, and rapid industrialization, the confidence of investors for investments in housing and other residential projects have increased drastically in South Asia. As a consequence, the building and construction industry of South Asia has gained a significantly positive momentum during the past years, which has increased the consumption of pigments and coatings, and is anticipated to result in the lucrative growth of alumina trihydrate consumption in the South Asia region.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-335

Alumina Trihydrate Market: Vendor Insights

The report highlights some of the prominent market players, who have established themselves as key participants in the global alumina trihydrate market. Some of the examples of key players in the global alumina trihydrate market are Sumitomo Chemical Co. Ltd., Aluminum Corp. of China Ltd., Nabaltec AG, National Aluminium Company Ltd., Huber Engineered Materials, Almatis GmbH, and Albemarle Corporation, among others.

The global alumina trihydrate market is significantly consolidated with some players holding prominent shares of the market. These participants are offering alumina trihydrate under their popular brands such as Micral, Hymod, MoldX, Hydral, SpaceRite, Vertex, and Zerogen among others.

This FMI study offers market growth forecast for the 10-year assessment period, 2021-2031, and projects a strong 7.7% CAGR for market revenues through 2031.

Sulphur Coated Urea Market Revenues to Reach US$ 855 Mn in 2016

The global sulphur coated urea market is primarily driven by a few factors that include growing concerns about sustainability and cost minimization in the agriculture sector, stringent regulations on conventional fertilizers, increasing number of recreational arenas across the world that require turf grass such as golf courses and concerns about eutrophication. Furthermore, growing urbanization and increase in food consumption globally are also influencing demand for sulphur coated urea.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-938

Increasing urbanization, coupled with spending preferences on luxury amenities, has widened the application area for sulphur coated urea and catalyzed its demand worldwide. Owing to a substantial increase in the number of high-net-worth individuals, the trend of growing investments on recreational and sporting activities is expected to increase. Worldwide focus as well as development in sports infrastructure is paving the way for increased demand for sulphur coated urea owing to its complementary properties in non-agricultural activities.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-938

Market Segments

By region, North America and Asia Pacific Excluding Japan (APEJ) dominated the global sulphur coated urea market in 2015 in terms of revenue, together accounting for over 60% share of the overall market. APEJ and Latin America are forecast to expand at a relatively high CAGR during the forecast period.

Key players in the market are focusing on expanding their footprints in emerging markets largely through mergers and acquisitions. Consolidation in the sulphur coated urea industry has facilitated market leaders, such as Agrium Inc., to expand their businesses in various geographies, thereby increasing their market share.

By product type, polymer sulphur coated urea segment accounted for over 90.0% of the overall sulphur coated urea market in 2015 both in terms of value and volume. Expanding at a CAGR of around 4% over the forecast period, the segment is projected to dominate the market over 2016–2026.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-938

Competitive Landscape

Key market players covered in the report include Agrium Inc., Israel Chemicals Ltd., Syngenta AG, Andersons Inc., Yara International ASA, Harrell’s LLC, Koch Industries Inc., Haifa Chemicals Ltd., and J. R. Simplot Company. Most players in the market are engaged in various activities such as mergers and acquisitions, increasing investments in technological developments, geographical expansion and brand building via strong marketing strategies in order to sustain their position in the competitive market.

Global Laser Safety Glass Are Projected To Reach 6.3 Mn Units By The End Of 2029 & Robust 10% Volume CAGR During The Forecast Period 2019-2029

The global sales of laser safety glass are projected to reach 6.3 Mn units by the end of 2029, which translates into a robust 10% volume CAGR during the forecast period (2019-2029). A new Future Market Insights (FMI) report says that sales of laser safety glass are primarily driven by the growing usage of laser machines across end-use sectors. Laser safety glass is widely used in the healthcare industry, particularly dentistry and dermatology. Strict government regulations about the usage of personal protection equipment will remain crucial in fostering the demand for laser safety glass.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-885

Key Takeaways – Laser Safety Glass Market Study

  • Stringent regulations related to laser safety glass will drive the demand for laser safety glass in the global market. For instance, European standard (EN) 207:20091 outlines the requirement of laser safety glass to ensure workers’ safety and protection. This standard dictates that laser safety glass should be able to withstand 100 pulses from a pulsed laser or a continuous beam for at least 10 seconds, without any damage.
  • With the initiation of shorter pulsed and femtosecond lasers, eyewear protection has become increasingly more important because of the broadband nature of these sources. This factor is expected to significantly drive the demand for laser safety glass.
  • Laser safety glass are required in the military for self-protective purposes against enemy laser attacks and for defense from internal factors as well. Internal usage includes non-combat applications such as industrial, medical, logistics, weapons training, and research and development.
  • Furthermore, laser safety glass is also used for metal fabricating processes such as cutting, engraving, welding, 3D printing, and additive manufacturing.
  • The rapidly growing automotive industry in emerging economies such as China, India, and Brazil is further fueling the demand for laser safety glass.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-885

The market for laser safety glass is currently growing at a moderate pace as is a mature market in EU countries. However, it is showcasing healthy growth in Asian region. The market growth will be aided by enforcement of OSHA regulations in industrial engineering and workplace processes and other sites where the personnel are subjected to high intensity laser emissions and interferences. In terms of new end use verticals, defense will be a lucrative sector, encouraging new entrants in the market.

How is Market Structure Defined?

Dominated by established international players, the laser safety glass market is a consolidated one. Some of the key players in the laser safety glass market such as 3M, Honeywell International Inc., and Philips Safety Products Inc. hold a major share of market pie in terms of revenue, backed by long-term partnerships with consumers and well-established sales network across the continent.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-885

Know More About What the Report Covers

Future Market Insights (FMI), in its new global laser safety glass report, brings to fore an even-handed analysis of the global laser safety glass market, offering comprehensive information with historical demand data for 2014-2018, and forecast statistics for 2019-2029. The research study offers insightful aspects of the global laser safety glass market based on various categories such as technology (glass laser eyewear safety, polycarbonate safety glass, thin film glass, laser protective face shields, intense pulse light glass), application (automotive, medical, chemicals, military & defence, others), and region (North America, Latin America, Eastern Europe, Western Europe, Middle East and Africa, Asia Pacific Excl. Japan, and Japan).